Patients with GATA4 -low tumor expression showed a trend of lower OS than patients with high GATA4 expression in the tumors (Figure 7 A).
← all excerpts
GATA4 downregulation enhances CCL20-mediated immunosuppression in hepatocellular carcinoma.
1
—
—